Iridocorneal endothelial syndrome (ICE) is a rare condition characterized by the increased proliferation and migration of corneal endothelial cells to the iris and iridocorneal angle, leading to secondary angle-closure glaucoma, corneal edema, and atrophy of the iris. ICE is a group of disorders with three clinically distinct variants, including essential iris atrophy (EIA), Chandler syndrome (CS), and Cogan-Reese syndrome (CRS). If left untreated, each variant may progress to blindness. However, prompt diagnosis and multidisciplinary management can mitigate this catastrophic outcome. This activity reviews the pathophysiology, signs and symptoms, evaluation, differential diagnosis, and management of ICE and highlights the role of the interprofessional team in evaluating and treating patients with this rare condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/141745
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, All Practice Areas (e.g. ethics), General Surgery, Internal Medicine